1Linderpainter K. Jin M. Niedermajer N, et al. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart [J], Circ Res. 1990. 67: 546.
2Hilgers KF, Kuczera M, Wilhelm MJ. et al. Angiotensin formation in the isolated rat bindimb [J]. J Hypertens, 1989. 7: 789.
3Admirsal PJ,Derkx, FH, Danser AH, et al. Metabolism and production of angintensin Ⅰ in different vascular beds in subjects with hypertension [J]. Hypertension , 1990,15 (1) : 44.
4Strillmatter SM, Kapiloff MS, Snyder SH, et al, [^3H] Capopml binding to membrane associated angiotensia converting enzyme [J]. Biochem Biophs Res Commun, 1983, 112 (3): 1027.
5Subrier F, Alhene G F, Hubert C, et al. Two putative active centers in human angiotensin Ⅰ converting enzyme revealed by molecular cloning [J]. Proc Natt Acad Sci USA, 1988, 85 (24): 9386.
6Naftilan AJ, Zuo WM, Inglefinger J, et al. Localization and different regulation of angiotensinN mRNA expression in the veasel wall [J]. J Clin invest, 1991, 87 (4): 1330.
7Blaufarb IS, Sornenblick EH. The renin angintensin system in left ventricular remodeling [J]. Am J Cardiol, 1996, 77 (13) 80.
8Olivetti G, Capasso JM, Meggs LG. Callular basis of chronic ventricular remodeling after myocardial infarction in rats [J]. Cire Res, 1991, 68: 856.
9Teerlink JR. Neurohumoral mechanism in heart failure: a central role for the renin angiotensin system [J]. J Cardiovasc Pharmacol, 1996, 27 (suppl 2): S1-8.
10Nakamsru M, Jackson EK, Inagami T, et al. Bata-adrenorecep-tor-mediated release of angiotensin Ⅱ for mesenteric arteries [J]. Am J Physiol, 1986, 250 (1pt2):H144.
同被引文献8
1Arnold JM,Liu P, Demers C,et al.Canadian cardiovascular society consensus conference recommendations on heart failure 2006:diagnosis and management[J]. Can J Cardiol,2006,22(1):23--45.
2Bristow MR,Saxon LA,Boehmer J,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure[J].N Engl J Meal,2004,350(21):2140-2150.
3叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2000.313.
4Chon JN.New concepts regarding events that lead to endstage heart disease.Cardiovasc Drugs Therapy,1995,9:4 389.
